SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer. Chae YK, Othus M, Patel SP, Wilkinson KJ, et al. Clin Cancer Res 2024 Oct 17. doi: 10.1158/1078-0432.CCR-24-0606.

Read + Share

Amedeo Smart

Independent Medical Education

Chae YK, Othus M, Patel SP, Wilkinson KJ, et al. SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer. Clin Cancer Res 2024 Oct 17. doi: 10.1158/1078-0432.CCR-24-0606.
PMID: 39417692